The Bile Acid Sequestrant Acceptability Scale validation study

Abstract

The BASA scale effectively distinguished between an orange-flavoured BAS powder and a commercial orange-flavour control powder.

Colesevelam, Ezetimibe, and Patients With Type 2 Diabetes Mellitus

“…Compared with older bile acid sequestrant resins, colesevelam HCl has improved acceptability and tolerability in terms of those characteristics reported to most influence long-term use (eg, taste). 30,31 In the current study, we examined the impact of the index dosage form (oral suspension vs tablet) on treatment patterns within the colesevelam HCl cohort. Mean persistence was shorter with the oral suspension compared with the tablet form, possibly because of shorter mean follow-up on the oral suspension form or because the oral suspension is sometimes used for therapeutic reasons other than metabolic effects, such as in treating gastrointestinal disorders.…”

Comparing apples and pears: assessment of lipid-lowering therapies differentiated by side effects

“…In this issue, Bays et al. (17) describe the clinical validation of a bile acid sequestrant acceptability (BASA) scale. This supersedes previous ‘wine‐tasting’ tests and combines taste, texture, appearance and ‘mixability’ in a points scoring system.…”